The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
Open accessAbstract
BACKGROUND: Iron overload and hemochromatosis are common, treatable conditions. HFE genotypes, levels of serum ferritin, transferrin saturation values, and self-reported medical history were studied in a multiethnic primary care population. METHODS: Participants were recruited from primary care practices and blood-drawing laboratories. Blood samples were tested for transferrin saturation, serum ferritin, and C282Y and H63D mutations of the HFE gene. Before genetic screening, participants were asked whether they had a history of medical conditions related to iron overload. RESULTS: Of the 99,711 participants, 299 were homozygous for the C282Y mutation. The estimated prevalence of C282Y homozygotes was higher in non-Hispanic whites (0.44 percent) than in Native Americans (0.11 percent), Hispanics (0.027 percent), blacks (0.014 percent), Pacific Islanders (0.012 percent), or Asians (0.000039 percent). Among participants who were homozygous for the C282Y mutation but in whom iron overload had not been diagnosed (227 participants), serum ferritin levels were greater than 300 mug per liter in 78 of 89 men (88 percent) and greater than 200 microg per liter in 79 of 138 women (57 percent). Pacific Islanders and Asians had the highest geometric mean levels of serum ferritin and mean transferrin saturation despite having the lowest prevalence of C282Y homozygotes. There were 364 participants in whom iron overload had not been diagnosed (29 C282Y homozygotes) who had a serum ferritin level greater than 1000 microg per liter. Among men, C282Y homozygotes and compound heterozygotes were more likely to report a history of liver disease than were participants without HFE mutations. CONCLUSIONS: The C282Y mutation is most common in whites, and most C282Y homozygotes have elevations in serum ferritin levels and transferrin saturation. The C282Y mutation does not account for high mean serum ferritin levels and transferrin saturation values in nonwhites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox, D. R., & Hinkley, D. V. (1974) · doi:10.1007/978-1-4899-2887-0 · Cited by 3,089
Genetic data analysis II: methods for discrete population genetic data
(1996) · Choice Reviews Online · doi:10.5860/choice.34-2150 · Cited by 1,630
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992
Long-term survival in patients with hereditary hemochromatosis
Niederau, C., Fischer, R., Purschel, A., Stremmel, W., Haussinger, D., & Strohmeyer, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613000 · Cited by 890
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J., & Gelbart, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07447-0 · Cited by 823
A Population-Based Study of the Clinical Expression of the Hemochromatosis Gene
Olynyk, J. K., Cullen, D. J., Aquilia, S., Rossi, E., Summerville, L., & Powell, L. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411002 · Cited by 702
Measurements of iron status in patients with chronic hepatitis
Di Bisceglie, A. M., Axiotis, C. A., Hoofnagle, J. H., & Bacon, B. R. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90339-z · Cited by 391
Geography of HFE C282Y and H63D Mutations
Merryweather-Clarke, A. T., Pointon, J. J., Jouanolle, A. M., Rochette, J., & Robson, K. J. H. (2000) · Genetic Testing · doi:10.1089/10906570050114902 · Cited by 305
A. Åsberg, K. H. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750422747 · Cited by 296
Cited by
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease
Astle, W. J., Elding, H., Jiang, T., Allen, D., Ruklisa, D., Mann, A. L., Mead, D., Bouman, H., Riveros-Mckay, F., Kostadima, M. A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.042 · Cited by 1,224
“The enrichment overlaps included a known pathogenic missense variant (Landrum et al., 2016) in myeloperoxidase deficiency (MPO) (Romano et al., 1997), and we identified additional known pathogenic variants in uncurated genes including CX3CR1 (HIV progression) (Faure et al., 2000) and hemochromatosis type 1 (HFE) (Adam…”
BackgroundContemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Moon, A. M., Singal, A. G., & Tapper, E. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.060 · Cited by 1,150
Biomarkers of Nutrition for Development—Folate Review
Bailey, L. B., Stover, P. J., McNulty, H., Fenech, M. F., Gregory, J. F., Mills, J. L., Pfeiffer, C. M., Fazili, Z., Zhang, M., Ueland, P. M., et al. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.206599 · Cited by 1,136
Dilated cardiomyopathy: the complexity of a diverse genetic architecture
Hershberger, R. E., Hedges, D. J., & Morales, A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.105 · Cited by 1,025
Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis
Allen, K. J., Gurrin, L. C., Constantine, C. C., Osborne, N. J., Delatycki, M. B., Nicoll, A. J., McLaren, C. E., Bahlo, M., Nisselle, A. E., Vulpe, C. D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073286 · Cited by 731
Self-citationBacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W., & Tavill, A. S. (2011) · Hepatology · doi:10.1002/hep.24330 · Cited by 723
Self-citationHereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Pietrangelo, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.013 · Cited by 615
EASL clinical practice guidelines for HFE hemochromatosis
European Association for the Study of the Liver (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.001 · Cited by 587
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
Kowdley, K. V., Belt, P., Wilson, L. A., Yeh, M. M., Neuschwander–Tetri, B. A., Chalasani, N., Sanyal, A. J., & Nelson, J. E. (2012) · Hepatology · doi:10.1002/hep.24706 · Cited by 543
Brissot, P., Pietrangelo, A., Adams, P. C., de Graaff, B., McLaren, C. E., & Loréal, O. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.16 · Cited by 430
Self-citationA wellness study of 108 individuals using personal, dense, dynamic data clouds
Price, N. D., Magis, A. T., Earls, J. C., Glusman, G., Levy, R., Lausted, C., McDonald, D. T., Kusebauch, U., Moss, C. L., Zhou, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3870 · Cited by 427
The Role of Iron in Diabetes and Its Complications
Swaminathan, S., Fonseca, V. A., Alam, M. G., & Shah, S. V. (2007) · Diabetes Care · doi:10.2337/dc06-2625 · Cited by 423
Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
Dongiovanni, P., Fracanzani, A. L., Fargion, S., & Valenti, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.008 · Cited by 362
Biomarkers of Nutrition for Development (BOND)—Iron Review
Lynch, S., Pfeiffer, C. M., Georgieff, M. K., Brittenham, G., Fairweather-Tait, S., Hurrell, R. F., McArdle, H. J., & Raiten, D. J. (2018) · The Journal of Nutrition · doi:10.1093/jn/nxx036 · Cited by 336
An overview of molecular basis of iron metabolism regulation and the associated pathologies
Silva, B., & Faustino, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.03.011 · Cited by 300
“It represents approximately 90% of the total cases of hemochromatosis [169].”
BackgroundValenti, L., Fracanzani, A. L., Bugianesi, E., Dongiovanni, P., Galmozzi, E., Vanni, E., Canavesi, E., Lattuada, E., Roviaro, G., Marchesini, G., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.013 · Cited by 281
ACG Clinical Guideline: Hereditary Hemochromatosis
Kowdley, K. V., Brown, K. E., Ahn, J., & Sundaram, V. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000315 · Cited by 272
Powell, L. W., Seckington, R. C., & Deugnier, Y. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01315-x · Cited by 266
Metallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Orchestration of Iron Homeostasis
Fleming, R. E., & Bacon, B. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmp048363 · Cited by 258
A role of PIEZO1 in iron metabolism in mice and humans
Ma, S., Dubin, A. E., Zhang, Y., Mousavi, S. A. R., Wang, Y., Coombs, A. M., Loud, M., Andolfo, I., & Patapoutian, A. (2021) · Cell · doi:10.1016/j.cell.2021.01.024 · Cited by 232
Zhao, Z., Li, S., Liu, G., Yan, F., Ma, X., Huang, Z., & Tian, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041641 · Cited by 227
Association between iron overload and osteoporosis in patients with hereditary hemochromatosis
Valenti, L., Varenna, M., Fracanzani, A. L., Rossi, V., Fargion, S., & Sinigaglia, L. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0701-4 · Cited by 203
Pilling, L. C., Tamosauskaite, J., Jones, G., Wood, A. R., Jones, L., Kuo, C.-L., Kuchel, G. A., Ferrucci, L., & Melzer, D. (2019) · BMJ · doi:10.1136/bmj.k5222 · Cited by 198
Iron storage disease: Facts, fiction and progress
Beutler, E. (2007) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2007.03.009 · Cited by 101
Genetic mechanisms and modifying factors in hereditary hemochromatosis
Weiss, G. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.201 · Cited by 82
Grosse, S. D., Gurrin, L. C., Bertalli, N. A., & Allen, K. J. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.121 · Cited by 76
Zimmermann, M. B., Fucharoen, S., Winichagoon, P., Sirankapracha, P., Zeder, C., Gowachirapant, S., Judprasong, K., Tanno, T., Miller, J. L., & Hurrell, R. F. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.1026 · Cited by 69
Hemochromatosis and Vibrio vulnificus Wound Infections
Barton, J. C., & Acton, R. T. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31819069c1 · Cited by 67
Self-citationInherited disorders of iron metabolism
Camaschella, C., & Poggiali, E. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283425591 · Cited by 59
Major depression and suicide attempts in patients with liver disease in the United States
Le Strat, Y., Le Foll, B., & Dubertret, C. (2015) · Liver International · doi:10.1111/liv.12612 · Cited by 50
The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study
Rogowski, W. H. (2009) · Medical Decision Making · doi:10.1177/0272989x08327112 · Cited by 42
Sex differences in chronic liver disease and benign liver lesions
Cooper, K. M., Delk, M., Devuni, D., & Sarkar, M. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100870 · Cited by 38
Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis
Benyamin, B., Esko, T., Ried, J. S., Radhakrishnan, A., Vermeulen, S. H., Traglia, M., Gögele, M., Anderson, D., Broer, L., Podmore, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms5926 · Cited by 30
“Data and DNA samples from HFE C282Y homozygotes in the HEIRS study 27 were obtained from the NIH Biologic Specimen and Data Repository Information Coordinating Center ( BioLINCC ) (https://biolincc.nhlbi.nih.gov/home/)].”
Prevalence of iron deficiency using 3 definitions among women in the US and Canada
Barton, J. C., Wiener, H. W., Barton, J. C., & Acton, R. T. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.13967 · Cited by 15
Self-citation
Metadata
- Authors
- Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., Dawkins, F. W., Acton, R. T., Harris, E. L., Gordeuk, V. R., Leiendecker-Foster, C., Speechley, M., Snively, B. M., Holup, J. L., Thomson, E., & Sholinsky, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-04-28
- Volume
- 352
- Issue
- 17
- Pages
- 1769-1778
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2160400039
- Cited by
- 775
- References
- 32
- FWCI
- 31.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.